Active Biotech AB (OSTO:ACTI) Accounts Payable: kr0.00 Mil (As of Mar. 2026)


OSTO:ACTI Active Biotech AB OSTO:ACTI
28 GF Score
Price kr5.32
! 1 Warning Sign
View Full Analysis

What is Active Biotech AB Accounts Payable?

Active Biotech AB OSTO:ACTI -2.39% 28 Accounts Payable is kr0.00 Mil as of Mar. 2026. GuruFocus rates OSTO:ACTI with a GF Score™ of 28/100. The stock has 1 warning sign investors should review.

Active Biotech AB's Accounts Payable for the quarter that ended in Mar. 2026 was kr0.00 Mil.

Active Biotech AB's quarterly Accounts Payable increased from Sep. 2025 (kr0.00 Mil) to Dec. 2025 (kr4.92 Mil) but then declined from Dec. 2025 (kr4.92 Mil) to Mar. 2026 (kr0.00 Mil).

Active Biotech AB's annual Accounts Payable declined from Dec. 2023 (kr3.17 Mil) to Dec. 2024 (kr1.45 Mil) but then increased from Dec. 2024 (kr1.45 Mil) to Dec. 2025 (kr4.92 Mil).

Active Biotech AB Accounts Payable Related Terms

Active Biotech AB Accounts Payable Historical Data

* Premium members only.

The historical data trend for Active Biotech AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Active Biotech AB Accounts Payable Chart

Active Biotech AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.76 3.53 3.17 1.45 4.92

Active Biotech AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 4.92 0.00
OSTO:ACTI
28GF Score
Active Biotech AB OSTO:ACTI
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Active Biotech AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of kr0.00 Mil mean?
Active Biotech AB (OSTO:ACTI) has a Accounts Payable of kr0.00 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Active Biotech AB and its competitors.
Is Active Biotech AB's Accounts Payable too high?
Active Biotech AB's current Accounts Payable is kr0.00 Mil. Overall, Active Biotech AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Active Biotech AB's Accounts Payable compare to VRTX and REGN?
Active Biotech AB's Accounts Payable of kr0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Active Biotech AB and its competitors. Active Biotech AB's current Accounts Payable is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Active Biotech AB stock overvalued right now?
Active Biotech AB (OSTO:ACTI) has a current Accounts Payable of kr0.00 Mil. The current Accounts Payable is kr0.00 Mil. Active Biotech AB's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Active Biotech AB (OSTO:ACTI), the current Accounts Payable is kr0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Active Biotech AB Business Description

Other Exchanges 0GQU:UKBTP:Germany
Address Scheelevagen 22, P.O. Box 724, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
28GF Score

Get the complete analysis for OSTO:ACTI

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.32
Price